Kuwait

The primary regulatory authority governing health products in Kuwait is the Drug and Food Control General Administration (DFCA) operating under the Ministry of Health (MOH). The DFCA oversees the registration, licensing, and post-market surveillance of pharmaceuticals, medical devices, diagnostics, and increasingly digital health solutions. The main legislative framework is grounded in the Public Health Law and associated ministerial decrees, which establish requirements for product registration, importation, and distribution. All health products must obtain official registration approval from the DFCA before they may be marketed or distributed within Kuwait. The approval process generally involves submission of a dossier, technical review, and where necessary, laboratory testing or inspection of manufacturing facilities.

For pharmaceutical and health product submissions, Kuwait generally accepts dossiers prepared in the Common Technical Document (CTD) format, aligning with international harmonization standards. Applicants are required to appoint a locally registered authorized agent or distributor to act as the in-country representative throughout the registration process. Kuwait is a member of the Gulf Cooperation Council (GCC) and participates in the GCC Centralized Drug Registration program coordinated by the Gulf Health Council, which allows for a degree of harmonized review across member states and can streamline simultaneous registration in multiple GCC markets. Supporting documentation typically required includes certificates of pharmaceutical product (CPP), GMP certificates, clinical evidence, labeling compliant with Arabic language requirements, and proof of registration in the country of origin. Recent reforms have focused on digitizing submission processes and aligning more closely with GCC-wide regulatory harmonization initiatives.

Public procurement of health products in Kuwait is primarily centralized through the Ministry of Health, which oversees the national health system and manages the bulk of public sector purchasing for hospitals, polyclinics, and government health facilities. The Central Tenders Committee (CTC), established under the Government Tenders Law, serves as the principal mechanism for large-scale government procurement, including health products. Tenders are published publicly and suppliers must be registered with the relevant government bodies. Procurement decisions are heavily influenced by the MOH formulary and approved product lists, and all products must hold valid DFCA registration prior to eligibility for public tender. Budget cycles and tender processes can introduce significant lead times, and contracts are frequently awarded on an annual or multi-year basis to approved local agents representing international manufacturers.

The private healthcare sector in Kuwait is growing, encompassing private hospitals, clinics, and pharmacies that procure health products independently through licensed local distributors and importers without reliance on the CTC process, though all products must still carry valid MOH registration. Kuwait's high-income status means it is not typically a recipient of donor-funded health procurement channels such as UNICEF Supply Division, the Global Fund, Gavi, or USAID health commodity programs, which are generally directed toward lower- and middle-income countries. There are no significant parallel donor procurement pathways operating in the Kuwaiti market. However, Kuwait does participate in GCC-level group purchasing discussions and benefits from regional pricing frameworks negotiated through the Gulf Health Council, which can influence reference pricing and procurement benchmarks across the public sector.